Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations

Psychopharmacology

Volumn 231, Issue 15, 2014, Pages 3031-3040

  Varani, Andrés P ^a   Aso, Ester ^b,d   Moutinho, Lirane MacHado ^a   Maldonado, Rafael ^b   Balerio, Graciela N ^a,c  

^a Instituto de Investigaciones Farmacologicas   (Argentina)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Baclofen; Mice; Nicotine; Reward; Withdrawal

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; NICOTINE; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; NALOXONE; NARCOTIC ANTAGONIST; NICOTINIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; COMPARATIVE STUDY; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DYSPHORIA; ELEVATED PLUS MAZE TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOKING CESSATION; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; ANIMAL; ANXIETY; AVOIDANCE BEHAVIOR; CONDITIONING; DEPTH PERCEPTION; DRUG EFFECTS; METABOLISM; MOVEMENT (PHYSIOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BACLOFEN; CONDITIONING (PSYCHOLOGY); GABA-B RECEPTOR AGONISTS; MALE; MICE; MOVEMENT; NALOXONE; NARCOTIC ANTAGONISTS; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, GABA-B; REWARD; SPACE PERCEPTION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 84904439970     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3469-6     Document Type: Article

References (75)

1. Abreu-Villaça Y, Nunes F, do E Queiroz-Gomes F, Manhães AC, Filgueiras CC (2008) Combined exposure to nicotine and ethanol in adolescent mice differentially affects anxiety levels during exposure, short-term, and long-term withdrawal. Neuropsychopharmacology 3(3):599-610
2. Adams ML, Cicero TJ (1998) Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal. Eur J Pharmacol 345(2):R1-R2 (Pubitemid 28212358)
3. Balerio GN, Rubio MC (2002) Baclofen analgesia: involvement of the GABAergic system. Pharmacol Res 46(3):281-286 (Pubitemid 35300768)
4. Balerio GN, Aso E, Berrendero F, Murtra P, Maldonado R (2004) Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 20:2737-2748 (Pubitemid 39573789)
5. Balerio GN, Aso E, Maldonado R (2005) Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 181:260-269 (Pubitemid 41492196)
6. Berrendero F, Kieffer BL, Maldonado R (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in muopioid receptor knock-out mice. J Neurosci 22(24):10935-10940 (Pubitemid 36005169)
7. Berrendero F, Mendizábal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, Maldonado R (2005) Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 25(5):1103-1112 (Pubitemid 40268951)
8. Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R (2010) Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev 35(2):220-231
9. Biała G, Budzyńska B, Kruk M (2005) Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice. Pharmacol Rep 57(6):755-760
10. Carboni E, Bortone L, Giua C, Di Chiara G (2000) Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend 58(1-2):93-102
11. Castañé A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Lack of CB1 cannabinoid receptors modifies nicotine behaviour a l responses, but not nicotine abstinence. Neuropharmacology 43:857-867 (Pubitemid 35221396)
12. Castañé A, Soria G, Ledent C, Maldonado R, Valverde O (2006) Attenuation of nicotine-induced rewarding effects in A2A knockout mice. Neuropharmacology 51(3):631-640 (Pubitemid 44215968)
13. Cheeta S, Irvine EE, Kenny PJ, File SE (2001) The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology (Berl) 155:78-85 (Pubitemid 32295772)
14. Chester JA, Cunningham CL (1999) Baclofen alters ethanol-stimulated activity but not conditioned place preference or taste aversion in mice. Pharmacol Biochem Behav 63(2):325-331 (Pubitemid 29234113)
15. Colombo G, Agabio R, Carai MA, Lobina C, Pani M, Reali R, Addolorato G, Gessa GL (2000) Ability of baclofen in reducing alcohol intake and withdrawal severity: I-Preclinical evidence. Alcohol Clin Exp Res 24(1):58-66 (Pubitemid 30062782)
16. Corrigall WA, Coen KM, Adamson KL, Chow JZ (2000) Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology (Berl) 149:107-114 (Pubitemid 30238947)
17. (B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65(3):209-220
18. Dalvi A, Rodgers RJ (1996) GABAergic influences on plus-maze behavior in mice. Psychopharmacology (Berl) 128(4):380-397 (Pubitemid 26417680)
19. Dani JA (2001) Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 49(3):166-174
20. Decker MW, Brioni JD, Bannon AW, Arneric SP (1995) Diversity of neuronal nicotinic acetylcholine receptors: lessons from behaviour and implications for CNS therapeutics. Life Sci 56(8):545-570
21. Diaz SL, Kemmling AK, Rubio MC, Balerio GN (2001) Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice. Behav Pharmacol 12:75-79 (Pubitemid 32202897)
22. Epperson CN, Toll B, Wu R, Amin Z, Czarkowski KA, Jatlow P, Mazure CM, O'Malley SS (2010) Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug Alcohol Depend 112(1-2):1-8
23. Fadda P, Scherma M, Fresu A, Collu M, Fratta W (2003) Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 50(1):1-6 (Pubitemid 37034107)
24. Fattore L, Cossu G, Martellotta MC, Fratta W (2002) Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol 37(5):495-498
25. Fattore L, Spano MS, Cossu G, Scherma M, Fratta W, Fadda P (2009) Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents. Eur Neuropsychopharmacol 19:487-498
26. File SE, Zharkovsky A, Gulati K (1991) Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rat. Neuropharmacology 30(2):183-190
27. File SE, Andrews N, Wu PY, Zharkovsky A, Zangrossi H Jr (1992) Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience. Eur J Pharmacol 218:9-14
28. B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend 103(1-2):30-36
29. Gilbert DG, Robinson JH, Chamberlin CL, Spielberger CD (1989) Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie. Psychophysiology 26(3):311-320 (Pubitemid 19162443)
30. Heinrichs SC, Leite-Morris KA, Carey RJ, Kaplan GB (2010) Baclofen enhances extinction of opiate conditioned place preference. Behav Brain Res 207(2):353-359
31. Hodgson SR, Hofford RS, Norris CJ, Eitan S (2008) Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal. Behav Pharmacol 19(8):805-811
32. Houdi AA, Dasgupta R, Kindy MS (1998) Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res 799(2):257-263 (Pubitemid 28351255)
33. Irvine EE, Cheeta S, File SE (2001) Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal. Pharmacol Biochem Behav 68:319-325 (Pubitemid 32231194)
34. Ise Y, Narita M, Nagase H, Suzuki T (2000) Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats. Psychopharmacology (Berl) 151(1):49-54 (Pubitemid 30639839)
35. Isola R, Zhang H, Duchemin AM, Tejwani GA, Neff NH, Hadjiconstantinou M (2002) Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse. Neurosci Lett 325(1):67-71 (Pubitemid 34521980)
36. Jackson KJ, Martin BR, Changeux JP, Damaj MI (2008) Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 325(1):302-312 (Pubitemid 351439184)
37. Jackson KJ, McIntosh JM, Brunzell DH, Sanjakdar SS, Damaj MI (2009) The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J Pharmacol Exp Ther 331(2):547-554
38. Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav 70(4):531-549 (Pubitemid 34131647)
39. King AC, Cao D, O'Malley SS, Kranzler HR, Cai X, deWit H, Matthews AK, Stachoviak RJ (2012) Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women. J Clin Psychopharmacol 32(5):630-636
40. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24(2):97-129
41. Krishnan-Sarin S, Rosen MI, O'Malley SS (1999) Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence. Arch Gen Psychiatry 56(7):663-668 (Pubitemid 29315639)
42. Laviolette SR, van der Kooy D (2004) The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci 5:55-65 (Pubitemid 38076184)
43. Le Foll B, Wertheim CE, Goldberg SR (2008) Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neurosci Lett 443(3):236-240
44. Luo FC, Qi L, Lv T, Wang SD, Liu H, Nakamura H, Yodoi J, Bai J (2012) Geranylgeranylacetone protects mice against morphine-induced hyperlocomotion, rewarding effect, and withdrawal syndrome. Free Radic Biol Med 52(7):1218-1227
45. Ma YY, Cepeda C, Chatta P, Franklin L, Evans CJ, Levine MS (2012) Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressingmedium-sized spiny neurons. ASN Neuro. doi: 10.1042/AN20110063
46. Maldonado R, Saiardi A, Valverde O, Samad TA, Roques BP, Borrelli E (1997) Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388(6642):586-589 (Pubitemid 27340008)
47. Malin DH, Lake JR, Carter VA, Cunningham JS, Wilson OB (1993) Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl) 112:339-342 (Pubitemid 23278298)
48. Manhães AC, Guthierrez MC, Filgueiras CC, Abreu-Villaça Y (2008) Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL/6 mice. Behav Brain Res 193(2):216-224
49. Markou A (2008) Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci 363(1507):3159-3168
50. Markou A, Paterson NE, Semenova S (2004) Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation. Ann N Y Acad Sci 1025:491-503 (Pubitemid 39643899)
51. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, Tzavara E, Hanoune J, Roques BP, Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383(6603):819-823
52. Miura M, Saino-Saito S, Masuda M, Kobayashi K, Aosaki T (2007) Compartment-specific modulation of GABAergic synaptic transmission by mu-opioid receptor in the mouse striatum with green fluorescent protein-expressing dopamine islands. J Neurosci 27(36):9721-9728 (Pubitemid 47492174)
53. Mori T, Komiya S, Uzawa N, Inoue K, Itoh T, Aoki S, Shibasaki M, Suzuki T (2013) Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence. Eur J Pharmacol 715(1-3):238-245
54. Natividad LA, Tejeda HA, Torres OV, O'Dell LE (2010) Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adultmale rats. Synapse 64(2):136-145
55. Parrott AC, Garnham NJ (1998) Comparative mood states and cognitive skills of cigarette smokers, deprived smokers and nonsmokers. Hum Psychopharmacol 13:367-376 (Pubitemid 28358164)
56. B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl) 172(2):179-186
57. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167 (Pubitemid 16239568)
58. Picciotto MR, Corrigall WA (2002) Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 22:3338-3341 (Pubitemid 37465738)
59. Picciotto MR, Brunzell DH, Caldarone BJ (2002) Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13(9):1097-1106 (Pubitemid 34722033)
60. Pomerleau OF (1986) Nicotine as a psychoactive drug: anxiety and pain reduction. Psychopharmacol Bull 22(3):865-869
61. Rada P, Jensen K, Hoebel BG (2001) Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology (Berl) 157(1):105-110 (Pubitemid 32758966)
62. Rehni AK, Singh TG, Arora S (2012) SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice. Nicotine Tob Res 14(4):407-414
63. Sandoval MR, Palermo-Neto J (1985) Central nervous system supersensitivity and withdrawal from long-term treatment with barbital. Neuropharmacology 24(12):1247-1251 (Pubitemid 16182651)
64. SENASA (Resolución 617/2002): Requisitos, condiciones y procedimientos para la habilitación técnica de laboratorios que posean bioterios de producción, mantenimiento y local de experimentación
65. B receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats. Neuropharmacology 52(7):1555-1562
66. Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology (Berl) 117:2-10
67. Toll BA, White M, Wu R, Meandzija B, Jatlow P, Makuch R, O'Malley SS (2010) Low-dose naltrexone augmentation of nicotine replacement for smoking cessation with reduced weight gain: a randomized trial. Drug Alcohol Depend 111(3):200-206
68. Tome AR, Izaguirre V, Rosario LM, Cena V, Gonzalez-Garcia G (2001) Naloxone inhibits nicotine-induced receptor current and catecholamine secretion in bovine chromaffin cells. Brain Res 903:62-65 (Pubitemid 32904607)
69. Trigo JM, Zimmer A, Maldonado R (2009) Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin. Neuropharmacology 56:1147-1153
70. Valverde O, Fournie-Zaluski MC, Roques BP, Maldonado R (1996) The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology (Berl) 123(2):119-126
71. Varani AP, Balerio GN (2012) GABAB receptors involvement in the effects induced by nicotine on anxiety-related behaviour in mice. Behav Pharmacol 65:507-513
72. Varani AP, Moutinho LM, Calvo M, Balerio GN (2011) Ability of baclofen to prevent somatic manifestations and neurochemical changes during nicotine withdrawal. Drug Alcohol Depend 119:5-12
73. Varani AP, Moutinho LM, Bettler B, Balerio GN (2012) Acute behavioural responses to nicotine and nicotine withdrawal syndrome are modified in GABA(B1) knockout mice. Neuropharmacology 63:863-872
74. (B) receptor agonist only reduces ethanol drinking in light-drinking mice. Pharmacol Biochem Behav 102(2):233-240
75. Watkins SS, Stinus L, Koob GF, Markou A (2000) Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther 292(3):1053-1064 (Pubitemid 30136601)